用于治疗炎症疾病的金属有机框架
Heng Zhao1,2, Christian Serre1, Nathalie Steunou1,3
1Institut des Matériaux Poreux de Paris, ENS, ESPCI Paris, CNRS, PSL University, Paris, 75005, France.
Advanced healthcare materials
|March 21, 2025
概括
金属有机框架 (MOFs) 作为纳米载体,可用于治疗类风湿性关节炎和炎症性肠病等炎症性疾病. 混合MOF为先进的药物输送和组合疗法提供多功能平台.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 炎症是一种自然免疫反应,但未解决的炎症会导致诸如类风湿性关节炎 (RA),炎症性肠病 (IBD) 和糖尿病慢性伤口 (DCW) 等疾病.
- 由于复杂的炎症机制,目前的单一疗法往往不足,需要先进的药物输送系统.
- 金属有机框架 (MOF) 正在成为抗炎药物输送和多目标疗法的强有力的纳米载体.
研究的目的:
- 综合审查基于MOF的纳米药物用于炎症疾病治疗的最新进展.
- 突出MOF作为药物递送系统 (DDS) 和内在抗炎剂的潜力.
- 讨论MOF在治疗炎症疾病中的应用的挑战和未来研究方向.
主要方法:
- 关于用于炎症疾病的基于MOF的纳米药物研究的文献综述.
- 对MOF属性的分析,包括生物降解性,药物负载和刺激响应释放.
- 探索混合MOF,用于多功能治疗平台的纳米酶.
主要成果:
- 作为具有高药载荷能力和可调节释放动力学的可生物降解DDS,MOF显示出显著的承诺.
- MOFs表现出内在的抗炎和抗氧化特性,增强治疗疗效.
- 与纳米酶集成的混合MOF为协同抗炎作用提供了多功能平台.
结论:
- 基于MOF的纳米药物代表了治疗复杂炎症疾病的有希望的下一代战略.
- 对MOF功能化和混合系统的进一步研究对于优化治疗结果至关重要.
- MOFs为开发新型组合疗法提供了一个多功能平台,以解决炎症疾病中未满足的临床需求.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
01:29Inflammatory Bowel Disease IV: Pharmacological Management
83
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
83
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
123
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
123
01:29Drugs for Treatment of Ulcerative Colitis in IBD
114
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
114
01:28Inflammatory Response
1.7K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
329
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
329